ASHLEE DAUSCHA: Open Payments
NPI 1710643523 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 23 payments from 11 companies in 2025. Trend: 2023 $151 · 2024 $358 · 2025 $933
Food & beverage: $916Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $345 |
| Exact Sciences Corporation | 5 | $146 |
| ViiV Healthcare Company | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $94 |
| ABBVIE INC. | 1 | $90 |
| Gilead Sciences, Inc. | 2 | $36 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| Abbott Laboratories | 1 | $17 |
Products named: BREZTRI, AIRSUPRA, APRETUDE, The Cologuard Plus Collection Kit, REXULTI, VRAYLAR, Cologuard Collection Kit, FARXIGA.
Industry payments across AZ — which companies pay providers there.
